Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
1/6/2025
Chinese Researchers Use AI to Accelerates Discovery of Potential Glauc...
1/3/2025
Platinum Life Receives Conditional Approval for China's First Stem Cel...
1/3/2025
Gilead's Sunlenca (lenacapavir) Receives Marketing Approval in China
1/3/2025
Astellas' Vyloy (zolbetuximab) Receives Marketing Approval in China fo...
1/3/2025
Biocon Wins NMPA Approval for Tacrolimus Capsules in China
12/30/2024
TJ Bio Submits BLA for Genexine's Long-Acting Pediatric Growth Hormone...
12/30/2024
NMPA Approves Alpha/AZ's Zorifer for NSCLC
12/30/2024
2025 New Drug Outlook: Increasing Global Launch Share of Chinese Innov...
12/30/2024
TEVIMBRA Approved in the U.S. as First-line Treatment of G/GEJ in Com...
12/27/2024
China's Innovative Drug Approvals in 2024 and Blockbusters Anticipated...
12/26/2024
Alphamab Initiates Phase I/II Trial for HER2 ADC Bispecific and PD-L1 ...
12/25/2024
Auzone Submits NDA for TTYP01 to FDA, Anticipates 2025 Approval
12/24/2024
Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...
12/23/2024
Ascelia Pharma Secures Chinese Patent for 2nd-Generation Orviglance
12/19/2024
FDA Approves Betta/Xcovery's Ensartinib for NSCLC
12/16/2024
Sinopharm's Mpox Vaccine Gains Clinical Trial Approval in China
12/16/2024
Everest Medicines Announces Acceptance of the NDA for VELSIPITY
12/15/2024
HUTCHMED Announces Breakthru Designation in China for ORPATHYS and TA...
12/15/2024
US-China Renew Science and Technology Pact Amid Rising Tensions
12/12/2024
ARS Pharma Files for Approval of Neffy in China, Japan and Australia
12/11/2024
Generative AI Powers Insilico Medicine's Rapid Development of New IBD ...
12/10/2024
Eisai's Dotinurad Approved in China for Gout
12/10/2024
Huadong and Kiniksa's Rilonacept Gains Approval in China for Recurrent...
12/10/2024
Sperogenix's Vamorolone Approved in China for DMD
12/10/2024
Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...
12/10/2024
Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-...
12/10/2024
Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...
12/10/2024
Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...
12/10/2024
Hong Kong Takes Key Step Towards Becoming a Medical Hub with New Clini...
12/9/2024
Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024
Page:
6
/
11
Total number of articles:
323
:
[First]
[<<]
[4]
[5]
[6]
[7]
[8]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit